Dysphagia Management Market Report 2024

This Dysphagia Management industry report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The dysphagia management market size has grown strongly in recent years. It will grow from $3.83 billion in 2023 to $4.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to the rising incidence of stroke, the expanding aging population, an increase in neurodegenerative diseases, greater awareness of dysphagia, and a rise in chronic diseases.

The dysphagia management market size is expected to see strong growth in the next few years. It will grow to $5.32 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth expected during the forecast period can be attributed to the growing geriatric population, an increase in neurological disorders, a higher prevalence of chronic diseases, expanded healthcare infrastructure, and a rising demand for personalized and patient-centric dysphagia management solutions. Key trends anticipated include technological advancements, the use of telemedicine, developments in swallowing therapy technologies, personalized nutrition plans, and adaptive eating devices.

The increasing prevalence of digestive disorders is anticipated to propel the growth of the dysphagia management market. Digestive diseases encompass a broad spectrum of health issues affecting the digestive tract, ranging from mild conditions such as heartburn to severe illnesses such as cancer. The rise in digestive problems is attributed to factors including an aging population, lifestyle changes, dietary habits, stress, and obesity. Dysphagia management addresses these issues by implementing strategies to ease swallowing difficulties caused by conditions such as gastroesophageal reflux disease (GERD), achalasia, and esophageal cancer. For example, in January 2023, the UK Gut Health Report 2023, published by Holland & Barrett International Limited, indicated that 58% of people in the UK experienced gut health issues, with 45% reporting chronic problems lasting three months or more. Additionally, the National Health Service reported in September 2022 that 2.1 million admissions were due to gastrointestinal disorders as the primary diagnosis. Thus, the growing incidence of digestive disorders is expected to drive market growth for dysphagia management.

Key players in the dysphagia management market are focusing on developing innovative solutions, such as mobile applications for interactive video-based therapy sessions, to improve patient care and swallowing outcomes. These mobile applications provide a digital platform for real-time, remote therapeutic interactions via video, enabling personalized treatment and communication between therapists and patients. Features typically include video conferencing, session scheduling, progress tracking, and therapeutic exercises to enhance therapy effectiveness. For instance, in October 2023, Amrita Hospital, a healthcare provider based in India, launched SWALLO, a mobile app designed to assist individuals with dysphagia. The app offers interactive video-based therapy sessions with medical experts, allowing patients to receive therapeutic interventions without frequent hospital visits. It includes live interactive sessions by appointment and supports Malayalam with English subtitles, with plans to expand to all Indian languages.

In June 2024, Patheous Health, Inc., a US-based healthcare solutions provider, acquired DiagnosTEX, LLC, for an undisclosed amount. This acquisition is aimed at enhancing Patheous Health's diagnostic capabilities, integrating advanced technologies into its portfolio, and expanding its reach into new healthcare management areas. DiagnosTEX LLC, a US-based company, specializes in providing mobile dysphagia (swallowing disorder) consultations.

Major companies operating in the dysphagia management market are Nestlé Health Science, AstraZeneca plc, Novartis AG, F. Hoffmann-La Roche AG, Danone S.A., Medline Industries LP, Hormel Foods Corporation, Ingredion Incorporated, Deosen Biochemical Ltd., Fresenius Kabi AG, Phagenesis Ltd., Eisia Co. Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Bracco Diagnostics Inc., Nutricia Advanced Medical Nutrition, CP Kelco US Inc., Kent Precision Foods Group Inc., Rosemont Pharmaceuticals Limited, Flavour Creations, VitalStim UK Ltd., Slo Drinks Ltd.

North America was the largest region in the dysphagia management market in 2023. The regions covered in the dysphagia management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dysphagia management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Dysphagia management involves strategies and treatments designed to address and alleviate difficulties with swallowing, known as dysphagia. This condition can arise from various underlying issues, such as neurological disorders, structural abnormalities, or muscular problems. The goal of dysphagia management is to enhance the patient’s ability to swallow safely and comfortably, thereby reducing the risk of complications such as aspiration, malnutrition, and dehydration.

The primary products used in dysphagia management include drugs (such as proton pump inhibitors), feeding tubes, and nutritional solutions. Proton pump inhibitors (PPIs) are medications that decrease stomach acid production by inhibiting the enzyme responsible for acid secretion in the stomach wall. Treatments and therapies address different types of dysphagia, including esophageal dysphagia, oropharyngeal dysphagia, and severe dysphagia, and are distributed through various channels such as hospital pharmacies, retail pharmacies, and drug stores.

The dysphagia management market research report is one of a series of new reports that provides dysphagia management market statistics, including dysphagia management industry global market size, regional shares, competitors with a dysphagia management market share, detailed dysphagia management market segments, market trends and opportunities, and any further data you may need to thrive in the dysphagia management industry. This dysphagia management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dysphagia management market includes revenues earned by entities by providing services such as swallowing therapy, surgical interventions, dietitian consultation, and clinical evaluation and related products such as oral care products, voice restorative devices, cutlery with built-in assistance, swallowing devices and adaptive utensils. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.